Discontinuation report NOVOLIN GE TORONTO PENFILL

Last updated on 2024-10-15 History
Report ID 240227
Drug Identification Number 02024284
Brand name NOVOLIN GE TORONTO PENFILL
Common or Proper name NOVOLIN GE TORONTO PENFILL
Company Name NOVO NORDISK CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN INJECTION HUMAN BIOSYNTHETIC
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 5
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2025-12-31
Actual discontinuation date
Remaining supply date 2025-12-31
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 101-2476 ARGENTIA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 6M1
Company contact information 1 800 465 4334

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2024-10-15 French Compare
v2 2024-10-15 English Compare
v1 2024-10-15 English Compare

Showing 1 to 3 of 3